about
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Strategies for recruiting Hispanic women into a prospective cohort study of modifiable risk factors for gestational diabetes mellitus.A prospective cohort study of modifiable risk factors for gestational diabetes among Hispanic women: design and baseline characteristics.Smoking during pregnancy and risk of abnormal glucose tolerance: a prospective cohort study.Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort.Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.Migraine and breast cancer risk: a prospective cohort study and meta-analysis.Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSIIHuman papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition studyCirculating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.Teenage acne and cancer risk in US women: A prospective cohort studyEarly pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control studyInflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortNote: Radiochemical measurement of fuel and ablator areal densities in cryogenic implosions at the National Ignition Facility.Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study.The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC CohortAssociation between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study.Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohortAnalgesic use in relation to sex hormone and prolactin concentrations in premenopausal womenPremenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study IIRisk factors for prenatal depressive symptoms among Hispanic womenOvarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study.Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study IIPrediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.Analgesic use and patterns of estrogen metabolism in premenopausal women.Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohortReproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.A comparative study on the WCRF International/University of Bristol methodology for systematic reviews of mechanisms underpinning exposure-cancer associations.Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort.Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
P50
Q30252854-CA935700-06FF-44B5-AE17-08EC9315198EQ33517943-FA0E8B64-5D35-462A-9394-9126C44DC57CQ33686924-FA502019-D861-4DED-BE56-59927DC4BB1EQ33694901-1D478D30-E37D-45A0-A0D6-393DBCC2C1A5Q33916872-71CF8852-B461-4C51-B729-CE546EC655D9Q34621664-D7F998EA-737F-4A8E-ACD1-1409AF5C36F7Q34807665-94C12F74-0037-42CB-9331-C4CF3B3F2496Q34973549-1BB310AA-3D8D-4238-96B9-896C448A0BE3Q34974886-4ABBD379-EE71-4EA5-BCBD-6A527B6F6798Q35073210-A71B3B5A-EDD5-4C2D-82A8-C6A96F1C2C03Q35144254-C6E8942C-604D-4579-A7BA-094A5ADA17DFQ35549885-A8766706-CC06-46E0-A7FD-0301D1BD6698Q35582276-A4991738-ABC1-4239-B91A-97D3F3030201Q35598117-826CD17E-BD2F-4AA1-B123-E97F5D9E6BFDQ35680361-CB282B9B-33C1-4AEE-97E7-517C3EF16BF9Q35733175-BFD76C68-8FFC-4EF7-98B7-8B8C9ED55A84Q35826696-1808C8A4-7E03-459D-9C82-7405A7B92217Q35903393-5C9FDFDF-6E9D-48D0-BC6B-1DC19508B934Q36054974-97703F86-9080-4A28-A2A9-A13B9189ECC9Q36067573-8838F202-9F80-4697-A29F-3E5E984E40BAQ36443891-B0362966-CE7D-47F9-949F-066F4C942CB0Q36472414-3F72FF21-BFBB-4136-A718-B19DA9CD45A2Q36824033-B2FDBC63-3C0F-4C21-8681-CCB4606ADCB0Q36903340-30963823-D21D-4056-9243-255EDD1A3E2FQ37080909-517314C0-493A-481F-A7FF-40DAB278183AQ37234793-CF063EAA-FB97-4980-B812-E17E93E8ED4BQ37345248-FE52839E-5F54-48D3-96E6-6CEDABE8DC87Q37371389-A71ECDCF-E6C0-4538-BCD4-D2BCBE77A973Q37633486-A0770F35-4D53-4C4C-8D0C-609A3D2D04DBQ37686568-6456A2AC-C9F9-45A7-AF3C-0B14C6F774FBQ37713640-8FCA1E63-3D49-4F58-92C1-25E74BFAA85DQ38345889-875201F9-892C-41C0-BC2C-1E50576F2AADQ38650111-B6E1D005-7C1A-4C2F-BE96-197575310AC3Q38682103-71CA1F44-9B08-4E79-B52B-76A8CB455339Q38756834-0D212E49-ABCA-4882-A37B-F48DD7EB9695Q38851593-0F8642B3-3F40-4A21-968D-E3D11A616508Q39116052-CC995F45-E185-4CF2-B441-6B8112529A36Q40057472-EB084864-5F00-48B2-9EB8-1641A14A04EBQ40117216-A80F8BA7-A133-45E7-9ABA-AB1D70C558B7Q40263318-BA17CFAF-6ED8-4A80-B457-D3863863D9DE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Renée Turzanski Fortner
@ast
Renée Turzanski Fortner
@en
Renée Turzanski Fortner
@es
Renée Turzanski Fortner
@nl
Renée Turzanski Fortner
@sl
type
label
Renée Turzanski Fortner
@ast
Renée Turzanski Fortner
@en
Renée Turzanski Fortner
@es
Renée Turzanski Fortner
@nl
Renée Turzanski Fortner
@sl
altLabel
Fortner R
@en
Fortner RT
@en
R T Fortner
@en
Renee Turzanski Fortner
@en
Renee Turzanski-Fortner
@en
Renée T Fortner
@en
Renée T. Fortner
@en
prefLabel
Renée Turzanski Fortner
@ast
Renée Turzanski Fortner
@en
Renée Turzanski Fortner
@es
Renée Turzanski Fortner
@nl
Renée Turzanski Fortner
@sl
P106
P21
P31
P496
0000-0002-1426-8505